**¦**timed walk tests has been incorporated into studies of new therapeutic agents for patients with heart and lung disease.1"8 Recently, the 6-min walk test For editorial comment see page 310 (6'WT) has been shown to predict mortality in patients with symptomatic heart failure.5 The utility of the 6 'WT in assessing functional capacity and survival in patients with advanced heart failure has not been clearly established. Peak oxygen uptake (peak V02) and age-gender adjusted peak oxygen uptake (peak %Vo2) measured matic heart failure.9"17 In particular, peak V02 has also been used to determine the appropriateness and tim¬ ing of cardiac transplantation. 16 Measurement of peak V02 and peak % V02, however, requires sophisticated equipment and specially trained personnel. The purpose of the present study was to examine the utility of the 6'WT in patients with advanced heart failure undergoing cardiac transplant evaluation. Specifically, the study sought to examine whether results of the 6'WT might predict (1) peak V02 and peak %Vo2 and (2) survival in such patients.
Materials and Methods

Patient Population
Forty-five patients with advanced, symptomatic heart disease referred to the Massachusetts General Hospital Heart Failure Center for cardiac transplant evaluation comprised the study pop¬ ulation. Excluded from the study were The predefined criteria for terminating the 6'WT included the follo\ving: (1) signs or symptoms of significant distress (ie, confusion, stupor); (2) dizziness; (3) significant angina; (4) dyspnea; (5) fatigue; (6) severe musculoskeletal pain, includingleg claudication; (7) (12) an ataxic gait. Observed Percent Predicted Peak Oxygen Consumption (%) Figure 2 . Left: observed peak V02 and model-predicted peak V02. Right: observed percent predicted age-gender adjusted peak oxygen consumption and model-predicted percent predicted age-gender adjusted peak oxygen consumption. Figure 2 (right). 14, Fig 3) . Peak V02 greater than 14 mg/kg/min was predictive of long-term survival (p=0.025). In multivariate survival analysis, peak %Vo2 rather than peak V02 or distance ambulated during the 6'WT was selected as the only significant exercise predictor of long-term survival.
Discussion
The results of this study show that distance ambu¬ lated during the 6'WT following optimization of med¬ ical therapy predicts peak V02 and peak %Vo2 in pa¬ tients with advanced chronic heart failure referred for cardiac transplant evaluation. In this small cohort of patients, distance ambulated during the 6'WT less than 300 m also predicted the occurrence of death or hos¬ pital admission for inotropic or mechanical bridging to transplantation within the next 6 months. The 6'WT was found to be inferior to either peak V02 or peak %Vo2 in predicting long-term (>6 months) survival. Prediction of Peak V02 From the Results of the 6'WT To our knowledge, only one previous study has correlated 6 'WT findings with peak V02 in patients with chronic heart failure. Lipkin et al6 found a curvi¬ linear relationship between distance ambulated during the 6'WT and peak V02 and showed that while the distance ambulated by patients with a low peak V02 varied considerably, it varied less in patients with a higher peak V02. The authors of this study did not re¬ port the correlation coefficient of the 6 ing that the determinants of submaximal and maximal exercise capacity in patients with advanced heart fail¬ ure may differ.
Conclusion
The 6'WT total distance ambulated predicts peak V02 and 6-month event-free survival in patients with advanced chronic heart failure. In this population, however, peak V02 appears to be superior to the 6 
